CureVac N.V. Ordinary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CVAC Company Description
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GSK to develop a second-generation covid vaccine. CureVac's first attempt to develop a covid vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.
CVAC Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CVAC Smart Score
Score Breakdown
CVAC Company Description
Show More
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GSK to develop a second-generation covid vaccine. CureVac's first attempt to develop a covid vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CVAC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CVAC's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CVAC's company Twitter account
WallStreetBets
Number of mentions of CVAC in WallStreetBets Daily Discussion
CVAC News
Recent insights relating to CVAC
CNBC Recommendations
Recent picks made for CVAC stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CVAC
Corporate Flights
Flights by private jets registered to CVAC
Our Analysis